Life Giveth 生活赐予

David Chu
Partner of ShineWing Australia

The life of an accountant certainly seems far more enigmatic post-Ben Affleck’s portrayal of Christian Wolff in the movie ‘The Accountant’. For David Chu, life has always been an inspiring adventure, having lived, raised a beautiful family and managed a thriving business in two continents.

A dapper and disarming gentleman, Chu is affable and smart in appearance as well as intellectual capacity. He is comfortable in his impressive height, and strides well in an elegant suit that seems to be tailored just for him.

With a brilliant smile, he shared that he was raised in Hong Kong, graduated from the University of Hong Kong, with a degree in Economics and Accounting. He started looking beyond familiar shores, when it came to providing the most holistic education for his three children.

Having gone through a thorough search, the Chus focused on Australia with great interest. They found a cultural and well-balanced education system in Melbourne and soon set about to make it their home in the early 1990’s.

“I would say I came at the right time.  It was Paul Keating’s administration and he was keen for Australia to form closer business ties with Asia.” Hence a young David Chu started working for a mid-tier accounting firm, where he was primarily responsible for looking after Asian companies doing business in Australia and vice versa. After 15 years of trudging through rank and file, integration and learning about the businesses in a new country, David established ShineWing in Melbourne in 2008.

“ShineWing is the largest domestic accounting firm in China with a clear objective of becoming an internationally recognised provider of accounting, finance and advisory solutions. ShineWing has always been a leader in the globalisation of Chinese accounting firms.”

Branching out extensively, ShineWing established offices in Hong Kong in 2005, Singapore in 2006 and eventually in the able hands of David Chu, the Melbourne operation in 2008.

“I did not establish ShineWing’s presence in Australia at the best of times. It was during the 2007/2008 global financial crisis and everyone was sceptical about new business ventures. However, the level of trust and faith from ShineWing China was pivotal in my persistence with the business landscape here.”

“I strongly subscribe to the vision of our Chairman in China. Keep persisting. However long the journey, if you keep persisting, you will succeed.”

“It is also the vision of our Chairman for ShineWing to be a globally recognised, leading brand in the accounting profession, both within China and throughout the world. This can only be achieved from vision, persistence and excellence. Easy to quote excellence but difficult to attain. To us excellence is about the quality of our work, our people and our clients.”

Looks like ShineWing China is right about entrusting their brand to David Chu. Today the ShineWing entity ranks no. 20 in the world, based on revenue. They are also the first Chinese firm to achieve a world ranking position thus far.

Headquartered in Beijing, ShineWing has 22 offices in China. In 2014, the Australian office of ShineWing merged with Moore Stephens Melbourne to create a new brand in the market place; ShineWing Australia. Initially based out of Melbourne, the network continued its rapid expansion along the eastern seaboard of Australia and now offers clients access to over 30 Partners and 200 staff. With offices in Melbourne, Sydney and Brisbane and a wide-ranging clientele, ShineWing Australia continues to attract top senior talent and expand their geographical coverage to deliver extra value to their high-profile clients.

ShineWing’s expansion hasn’t been limited to Australia either. Over the last 12 months, the network has added offices in Pakistan, Egypt and India, as it assists clients capitalising on the opportunities associated with China’s “Belt and Road” initiative.

So what does David Chu the successful business man say about David Chu the family man? “There is no clear demarcation. I like to leave a grey area where business can interact with family. All my clients have become friends of my family and we get together with for dinner and social outings regularly.”

Unbelievable but this debonair individual is a grandfather of two. “My wife has done a great job in raising our daughter and two sons with love and care, while providing proper guidance all the time. Not an easy job and she does not get off at five or six o’clock like our business. Interestingly, all my children are now living and working in Hong Kong,” he smiles at the irony.

“We feel blessed. Transitioning here has been mostly easy and fun for us. In Melbourne, it’s all about footy, so I had to pick a team. Since I was based in Hawthorn earlier on, the choice was obvious and it turned out to be the right team for me after all. In Hong Kong we used to drink cognac but over here it is more about wine, so I attended wine classes to be able to swap stories,” he laughed good-heartedly.

“My wife and I try to do our bit for the community. She volunteers for the elderly while I get involved actively with the Fred Hollows Foundation, a non-profit organisation that provides cataract surgeries for people in Asia and Africa.” Fluent in English, Cantonese and Mandarin, David has also been a regular presenter on the Cantonese programme of SBS Radio on Australian economic affairs.

Having achieved all that, David has not forgotten about his Chinese heritage. “I aspire to be a role model for my children and intend to demonstrate a healthy balance in preserving our culture and successfully integrating with the Australian community and lifestyle.”












过去1年内,信永中和澳大利亚彰显了无限的发展潜能,分别在巴基斯坦,埃及和印度设立办事处,这是协助客户利用与中国相关的商务机会,即 “一带一路” 的策略。







Eliminating Disease 隔绝疾病

Professor Scott O’Neill
Founder & Head of the Eliminate Dengue Program

In the drier and temperate regions of Australia, many people may not regard mosquito-borne diseases as a serious issue, but they are a silent and prevalent killer for those who are closer to the equator.

The World Health Organisation (WHO) has ranked dengue fever as the most critical mosquito-borne viral disease in the world and the most rapidly spreading – with a 30-fold increase in global incidence over the past 50 years. Each year an estimated 390 million dengue infections occur around the world. Of these, 500,000 develop into dengue haemorrhagic fever, a more severe form of the disease, and dengue results in up to 25,000 deaths annually worldwide.

The statistics are alarming with over 2.5 billion people (more than 30% of the world’s population in over 100 countries at risk of infection). The most significant recent epidemics have occurred in South-east Asia, the Americas and the Western Pacific.

Deadly Dengue And More
For years, countries and governments have attempted to mitigate against the disease as well as more recent mosquito-borne disease threats such as Chikungunya and Zika. These measures have been largely ineffective. The Eliminate Dengue Program (EDP), a not-for-profit international collaboration led from Monash University in Australia – part of the Institute of Vector-Borne Disease – has an innovative solution to the transmission of such diseases.

The programme is headed by scientist, Professor Scott O’Neill and brings together scientific collaborators from around the world with a range of skills and experience including Wolbachia mosquito biology and ecology, dengue epidemiology and control, and public health education and promotion.

“In each country we work in, we partner with local people – local research institutes, governments, regulatory authorities, private enterprise and community members,” explains O’Neill, a biologist, who started this research more than 20 years ago.

What propelled O’Neill’s interest in the field study was to create a project and movement for a social purpose, instead of solely for scientific experimentation. After working in this field in Australia and the USA for several years, O’Neill’s team had a breakthrough with the Wolbachia innovation. The scientific team managed to transfer Wolbachia (commonly found in many insects such as the fruit fly) into the Aedes Agypti mosquito after more than 10 years.

Wolbachia is safe for humans, animals and the environment. It is found in many insects associated with human food and is widely consumed by humans; and it does not infect humans or other vertebrates. What the Eliminate Dengue Program innovation has done, is enable the Aedes agypti mosquito to block the transmission of disease. The EDP method uses Wolbachia, a naturally occurring bacteria, to reduce mosquito’s ability to transmit harmful human viruses such as Dengue, Chikungunya, and Zika. (Wolbachia has also been known to block the transmission of Yellow Fever and West Nile viruses.)

Expansion to Eliminate
Now, the EDP project has shown that its method of dengue control is feasible, thanks to initial field trials which have shown that the Wolbachia continues to block disease transmission. So far, the disease has been blocked for up to five years in communities where Wolbachia mosquitoes have been released. The team expects this to continue on an ongoing basis. Mathematical modelling by independent experts shows that the disease will continue to be blocked for 30 years.

“We are now further developing the method for low-cost, large-scale application across urban areas in countries affected by dengue.”

The programme is currently deploying its method in Australia, Vietnam, Indonesia, Brazil and Colombia with plans to expand into other top 20 countries affected by mosquito-borne diseases.

Within the next six years, the project aims to reduce the burden of the disease by 90%. As well as continuing to carry out large scale field releases in several countries, the team is planning large randomised trials in at least one city, Yogyakarta (Indonesia) until 2018-2019.

“We work with local universities, researchers, government agencies and communities in the countries we’re present in.” O’Neill and his team include close to 400 people working on the Eliminate Dengue project, with some 60 people based in the Monash University headquarter in Melbourne.

Unlike commercialised drugs administered to patients after an infection, EDP focuses on providing sustainable protection from disease. Application (release of mosquitoes with Wolbachia) is only done once over a short period (2-3 months) with no need for repetition.

“Our method is quite novel. People think you have to kill mosquitoes, but we have a different focus.”

A core part of the EDP method and innovation is the way the team involves communities. Key for O’Neill is “authentic engagement before, during and after mosquito releases”. The teams and partners engage with local communities and share details of what is involved, and share results as releases progress. They involve the media. Their focus is on accessible and transparent communication and a respectful and inclusive approach.

“Our field trials in five countries in over 30 sites have shown no reported adverse events; and good disease blocking,” says O’Neill. “In Indonesia we are conducting a large scale release and an impact study across Yogyakarta through to 2019.”

This type of new approach requires forward and bold thinking,” explains O’Neill.

While still recognised as a new method, funding for all science based interventions continues to be a challenge. Eliminate Dengue is a non-profit organisation that is looking to increase its philanthropic and government support base globally.

“We believe governments would prefer our method because it is safe, and takes financial pressure off their health systems, especially in countries where they are low on resources,” explains O’Neill.

The work is possible because of the vision of great philanthropists such as Bill and Melinda Gates, The Tahija family, the Gillespie family, the Wellcome Trust and governments including the Australian, UK and Brazilian governments and USAID. In order to expand the life changing work, the scientific team are looking for more partners and supporters.




众国家和政府多年来力图减轻疾病的致命性及蚊子传播疾病的威胁,如基孔肯亚和寨卡病毒,但许多措施效用有限。消除登革热计划(EDP)是一项非营利性国际合作项目,来自澳大利亚的蒙纳士大学(Monash University)-“媒介传播疾病研究所”属下的一部分,为传播类疾病提供创新的解决方案。

Scott O’Neill教授作为这项计划的主导者,他与世界各地科研合作者分享研讨一系列技能和经验:包括沃尔巴克氏菌体(Wolbachia)蚊子生物学和生态学,登革热传播病学和控制,还有公共卫生教育和促进。


至于推动他对实地研究的兴趣来自开创一个计划和互动的社会目标,而并非仅是用于科学实验。在澳大利亚和美国领域工作多年后,O’Neill的团队在沃尔巴克氏体科研成果方面取得突破,研究团队设法将沃尔巴克氏菌体(常见于昆虫,果蝇)转移到埃及伊蚊(Aedes aegypti),这项研究跨越10年。

而沃尔巴克氏菌体对人体,动物和环境是安全的,通常在与人类食物相关的昆虫中发现,并且被人类广泛使用,对于人类或其他脊椎动物不会造成感染。至于消除登革热计划能消解伊蚊并阻止疾病的传播,那是因为EDP利用天然沃尔巴克氏菌体,降低蚊子传播有害病毒例如登革热,基孔肯亚和寨卡的能力。(沃尔巴克氏菌体也证实阻断黄热病(Yellow Fever)和西尼罗病毒(West Nile viruses)的传播。)










许多慈善捐献证实这项工作的可行性,包括闻名的慈善资金会:比尔及梅林达·盖茨基金会(Bill & Melinda Gates),Tahija家族,Gillespie家族,维康信托(Wellcome Trust),还有澳大利亚、英国和巴西政府,包括美国国际开发署(USAID)都一致愿景。而为了扩大这项改变生活的意义工作,科学团队正在寻找更多的合作伙伴和支持者。

There are over 3000 species of mosquitoes in the world and only two (Aedes aegypti and Aedes albopictus) are responsible for transmitting dengue, chikungunya and Zika.) The O’Neill team’s innovation is focussed on the Aedes aegypti mosquito.

全世界有超过3000种类的蚊子,却只有埃及伊蚊(Aedesaegypti)和黑斑蚊(Aedes albopictus)这两种类会传播登革热、基孔肯亚和寨卡病毒。O’Neill团队新方式集中在消灭埃及伊蚊。

Baby’s First Aroma 婴儿原味香气

Catherine Cervasio
Founder of Aromababy

There is no greater love than a mother’s love for her children. While being a mother can change your life completely, it can also inspire you to do new things and explore avenues that will lead to good fortune.

That’s what Catherine Cervasio did in 1994 when she was pregnant with her first child and started Aromababy, an organic and natural baby skin-care line that’s now exalted by celebrities like John Trovolta, Princess Mary, Jamie Oliver and Kate Moss to name a few.

Catherine developed the Aromababy concept which would set the standard for baby goods worldwide and most importantly, natural, organic-rich baby skin care.

“I’ve always had a strong interest in natural health and well-being and completed a diploma in aromatherapy and massage. I was trained as an Infant Massage Instructor and worked in the area of product development of skin care products. With Aromababy, I wanted to offer natural baby products at a hospital level so that parents would have a choice in the type of baby care they want to use,” she said.

After 22 years, Aromababy is now sold in hospitals and highly recommended by midwives. It has also received numerous accolades in both Australia and overseas.

Some of the awards were the My Business Awards, Micro Business Awards and the Gift Awards. She has received many nominations for the Telstra Business Women’s Awards over recent years, received a Highly Commended (Export) and a Highly Commended status in past Australian Achiever Awards.

Aromababy achieved a Highly Commended Award in the Export Entrepreneur of the Year division of the My Business Awards recently and has won Iparenting Media Awards in USA for several products.

Of course, all these did not just come easily for the mother of two as she slowly worked the business from a small start-up to an international exporter that is setting the world standard for safe and natural baby products.

“In the first few years, the challenge was to educate customers as there was no other product like ours. We kept on growing and started exporting to the Middle East five years into the business. When we were approached by a Korean company, that presented us a big opportunity to export to Korea and signing the multi-million dollar contract catapulted the business even further.”

Aromababy then ventured to Singapore, Hong Kong, Taiwan and smaller parts of Europe. The biggest break was a few years ago when the business started exporting to China. But Catherine wanted to take the trade slow and steady as exporting to China is usually thought of as a get rich quick method. She worked to get the brand licensed there so that it could be sold in retail outlets.

“I’ve visited Shanghai a number of times and it’s a beautiful clean city. I’m also learning Chinese a little now as it’s really important to communicate and embrace other cultures and understand the people you’re doing business with.”

In addition to Aromababy’s therapeutic-grade aromatic product, there is also the aroma-free products that are essential for the baby’s first few weeks of life, as studies show that bland, unscented product or simply water to be the best and safest. “This range only has pure essential oils that have been specifically chosen and blended synergistically not only for their therapeutic properties, but to delight the senses and soothe the soul,” explained Catherine.


1994年,Catherine Cervasio怀了第一个孩子,同时启动开发”爱乐湄(Aromababy)”有机和天然婴儿护肤产品系列品牌。而这个婴儿护理品牌甚至赢得国际名流或巨星如John Trovolta, Princess Mary, Jamie Oliver 与Kate Moss等高度赞扬追捧。



这些奖项包括MyBusinessAwards,微型企业奖(Micro BusinessAwards)及GiftAwards。同时近年来她多次获得Telstra Business Women’s Awards的提名,受到出口部门的高度赞赏,并曾在澳大利亚成就大奖中荣获最佳推荐。

爱乐湄产品在MyBusinessAwards所属的出口企业家赢得高度推荐奖,其中一些优质产品获得美国Iparenting Media Awards的权威肯定。